Skip Nav Destination
1-7 of 7
Clin Sci (Lond) (1979) 56 (5): 501–504.
Published: 01 May 1979
...P. N. Durrington 1. Further observations from an earlier study in which phenobarbitone in a dose of 180 mg daily was administered to ten normal men and women for 3 weeks are reported. There was a significant increase in plasma high-denity-lipoprotein (HDL) cholesterol concentration and in the...
Clin Sci Mol Med (1978) 54 (5): 539–547.
Published: 01 May 1978
... relative storage capacity ( S ) was normal. Phenobarbitone treatment in four patients resulted in an increase in T m , and S decreased in two patients and remained unchanged in the other two. 5. These results support the hypothesis that there are several variants of Gilbert's syndrome and that the...
Clin Sci Mol Med (1977) 52 (2): 219–222.
Published: 01 February 1977
...A. R. Marsh; H. S. Fraser; A. Breckenridge; B. Lewis; G. R. Thompson 1. Four groups of rats received a liquid formula diet, given alone (control), or supplemented with either ethanol or phenobarbitone, or both together. 2. The ethanol-treated group showed a fall in plasma triglyceride and a rise in...
Clin Sci Mol Med (1976) 50 (5): 349–353.
Published: 01 May 1976
...P. N. Durrington; C. J. C. Roberts; Lyn Jackson; R. A. Branch; M. Hartog 1. Phenobarbitone in a dose of 180 mg daily was administered to ten normal subjects for 3 weeks. There was a significant increase in total plasma cholesterol, plasma low-density-lipoprotein cholesterol, plasma low-density...
Clin Sci Mol Med (1974) 46 (4): 511–518.
Published: 01 April 1974
... affinity constant ( K m ) was altered in these studies. 3. In contrast, administration of phenobarbitone in doses of 0·34 mmol 24 h −1 kg −1 (80 mg 24 h −1 kg −1 ) caused a significant increase in the microsomal protein content but there was no significant change in the values for the apparent V max. or...
Clin Sci Mol Med (1974) 46 (1): 1–17.
Published: 01 January 1974
... significantly impaired in the patients with Gilbert's syndrome and in those with congenital non-haemolytic jaundice when compared with the normal subjects, and was normal in the patient with haemolytic jaundice. 2. Treatment for 2 weeks with phenobarbitone (180 mg/day) lowered the plasma bilirubin concentration...
Clin Sci Mol Med (1973) 45 (2): 257–262.
Published: 01 August 1973
...N. E. Miller; P. J. Nestel 1. The effects of phenobarbitone on cholesterol and bile acid metabolism have been examined in healthy humans. 2. In three of four subjects the faecal excretion of bile acids was increased by phenobarbitone. This was associated with an increased pool size and turnover of...